Search Results 391-400 of 9275 for Mediate

  1. A Study of the Benefits and Risks of Nulojix® (Belatacept)-Based Maintenance Immune Rejection Suppression for Kidney Transplant Recipients - Mayo Clinic

    History of antibody mediated rejection; Positive T-cell lymphocytotoxic cross match; Proteinuria >1 g/day or >0.5 g/day if diabetic. Participating Mayo Clinic ...

  2. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    History of immune-mediated pneumonitis. Current or prior use of immunosuppressive medication within 14 days prior to the first dose of study treatment ...

  3. A Study To Investigate The Safety And Efficacy Of KQB168 As Monotherapy And In Combination In Participants With Advanced Solid Malignancies - Mayo Clinic

    * Known history of immune-mediated colitis and uncontrolled autoimmune diseases. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

  4. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

    ... mediated kidney transplant rejection. In addition, oral corticosteroid treatment significantly alters the frequency and function of Breg subsets, which ...

  5. A Study to Evaluate the Safety of TRV130 in Patients who have Acute Pain - Mayo Clinic

    Clinically significant, immune-mediated hypersensitivity reaction to opioids. Participating Mayo Clinic locations. Study statuses change often. Please contact ...

  6. A Study of the Safety, Pharmacodynamics, Effectiveness, and PK of TIMP-GLIA in Subjects with Celiac Disease - Mayo Clinic

    History of clinically confirmed immunoglobulin E (IgE)-mediated reaction and/or anaphylaxis to wheat (i.e., "wheat allergy"), barley or rye. Uncontrolled CD ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_web.xml

  8. Publications - David R. Deyle, M.D. - Mayo Clinic

    A genome-wide map of adeno-associated virus-mediated human gene targeting. Nat Struct Mol Biol. 2014 Nov; 21(11):969-75. Epub 2014 Oct 05. View PubMed ...

  9. SangKon Oh, Ph.D. - Mayo Clinic Faculty Profiles

    Oh's study in the areas of human regulatory B cells and antibody-mediated transplantation rejection will also aid the design of novel therapeutics for ...

  10. A Study Of NT-175 In Adult Subjects With Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation - Mayo Clinic

    * Active immune-mediated disease requiring systemic steroids or other immunosuppressive treatment (except if related to prior checkpoint inhibitor therapy)